Biblio
In vivo hematopoietic stem cell modification by mRNA delivery. Science. 2023;381(6656):436-443.
Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies. Mol Ther. 2021.
.